Investigator choice of standard therapy clinical trials

A Randomised Phase II Study of Roginolisib in Patients With Advanced/Metastatic Uveal Melanoma

This study is testing a new drug, roginolisib, for advanced uveal melanoma, a type of eye cancer that has spread. It compares roginolisib to standard treatments to see if it helps patients live longer and how it affects their quality of life. It's for adults whose cancer has grown after other treatments.